Study supports IDH gene as prognostic marker in anaplastic astrocytoma

The mutation status of a gene called IDH1 might have prognostic value for anaplastic astrocytomas, and that it may be worth exploring further whether IDH1 status can predict the best chemotherapy for these patients, a new study suggests. (Mehr in: Cancer News — ScienceDaily)